SEARCH

SEARCH BY CITATION

References

  • 1
    Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet 2003; 72: 25369.
  • 2
    Classon M, Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2002; 2: 9107.
  • 3
    Helt AM, Galloway DA. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 2003; 24: 15969.
  • 4
    Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, Nevins JR. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 1992; 89: 454953.
  • 5
    Krynska B, Gordon J, Otte J, Franks R, Knobler R, DeLuca A, Giordano A, Khalili K. Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein. J Cell Biochem 1997; 67: 22330.
  • 6
    Harris KF, Christensen JB, Imperiale MJ. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J Virol 1996; 70: 237886.
  • 7
    Howes KA, Ransom N, Papermaster DS, Lasudry JG, Albert DM, Windle JJ. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 1994; 8: 130010.
  • 8
    Mukai N, Kalter SS, Cummins LB, Matthews VA, Nishida T, Nakajima T. Retinal tumor induced in the baboon by human adenovirus 12. Science 1980; 210: 10235.
  • 9
    Gallimore PH, Grand RJ, Byrd PJ. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. Anticancer Res 1986; 6(3, Part B): 499508.
  • 10
    Egan C, Bayley ST, Branton PE. Binding of the Rb1 protein to E1A products is required for adenovirus transformation. Oncogene 1989; 4: 3838.
  • 11
    Gulliver GA, Herber RL, Liem A, Lambert PF. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice. J Virol 1997; 71: 590514.
  • 12
    Ewen ME, Ludlow JW, Marsilio E, DeCaprio JA, Millikan RC, Cheng SH, Paucha E, Livingston DM. An N-terminal transformation-governing sequence of SV40 large T antigen contributes to the binding of both p110Rb and a second cellular protein, p120. Cell 1989; 58: 25767.
  • 13
    Palazzi MA, Yunes JA, Cardinalli IA, Stangenhaus GP, Brandalise SR, Ferreira SA, Sobrinho SP, Villa LL. Detection of oncogenic human papillomavirus in sporadic retinoblastoma. Acta Opthalmol Scand 2003; 81: 3968.
  • 14
    Orjuela M, Castaneda V, Ridaura C, Lecona E, Leal C, Abramson D, Orlow I, Gerald W, Cordon-Cardo C. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clin Cancer Res 2000; 6: 401016.
  • 15
    Montoya-Fuentes H, Ramirez-Munoz M, Villar-Calvo V, Suarez-Rincon AE, Ornelas-Aguirre JM, Vazquez-Camacho G, Orbach-Arbouys S, Bravo-Cuellar A, Sanchez-Corona J. Identification of DNA sequences and viral proteins of 6 human papillomavirus types in retinoblastoma tissue. Anticancer Res 2003; 23: 285362.
  • 16
    Zeschnigk M, Lohmann D, Horsthemke B. A PCR test for the detection of hypermethylated alleles at the retinoblastoma locus. J Med Genet 1999; 36: 7934.
  • 17
    Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 35761.
  • 18
    Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001; 183: 155464.
  • 19
    Yuan CC, Miley W, Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods 2001; 91: 10917.
  • 20
    Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 2003; 112: 2333.
  • 21
    Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003; 70: 22839.
  • 22
    Leung AY, Chan M, Tang SC, Liang R, Kwong YL. Real-time quantitative analysis of polyoma BK viremia and viruria in renal allograft recipients. J Virol Methods 2002; 103: 516.
  • 23
    Taoufik Y, Gasnault J, Karaterki A, Pierre Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E. Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 1998; 178: 181620.
  • 24
    Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS, Procopio A. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994; 9: 178190.
  • 25
    Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet 2004; 364: 115766.
  • 26
    Shenk T. Adenoviridae: the viruses and their replication, 3rd edn. Philadelphia, PA: Lippincott-Raven, 1996.
  • 27
    Espinoza JP, Cardenas VJ, Luna CA, Fuentes HM, Camacho GV, Carrera FM, Garcia JR. Loss of 10p material in a child with human papillomavirus-positive disseminated bilateral retinoblastoma. Cancer Genet Cytogenet 2005; 161: 14650.
  • 28
    Goodwin EC, DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 2000; 97: 1251318.
  • 29
    Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 21328.
  • 30
    Tsuyama N, Miura M, Kitahira M, Ishibashi S, Ide T. SV40 T-antigen is required for maintenance of immortal growth in SV40-transformed human fibroblasts. Cell Struct Funct 1991; 16: 5562.
  • 31
    Heck DV, Yee CL, Howley PM, Munger K. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 1992; 89: 44426.
  • 32
    Gillison ML, Shah KV. Chapter 9: role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003; 31: 5765.
  • 33
    Rintala MA, Grenman SE, Puranen MH, Isolauri E, Ekblad U, Kero PO, Syrjanen SM. Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol 2005; 43: 37681.
  • 34
    Olatunbosun O, Deneer H, Pierson R. Human papillomavirus DNA detection in sperm using polymerase chain reaction. Obstet Gynecol 2001; 97: 35760.
  • 35
    Rintala MA, Grenman SE, Pollanen PP, Suominen JJ, Syrjanen SM. Detection of high-risk HPV DNA in semen and its association with the quality of semen. Int J STD AIDS 2004; 15: 7403.
  • 36
    Armbruster-Moraes E, Ioshimoto LM, Leao E, Zugaib M. Presence of human papillomavirus DNA in amniotic fluids of pregnant women with cervical lesions. Gynecol Oncol 1994; 54: 1528.
  • 37
    Worda C, Huber A, Hudelist G, Schatten C, Leipold H, Czerwenka K, Eppel W. Prevalence of cervical and intrauterine human papillomavirus infection in the third trimester in asymptomatic women. J Soc Gynecol Invest 2005; 12: 4404.
  • 38
    Eppel W, Worda C, Frigo P, Ulm M, Kucera E, Czerwenka K. Human papillomavirus in the cervix and placenta. Obstet Gynecol 2000; 96: 33741.
  • 39
    Donovan SL, Schweers B, Martins R, Johnson D, Dyer MA. Compensation by tumor suppressor genes during retinal development in mice and humans. BMC Biol 2006; 4: 14.
  • 40
    Dorries K. Molecular biology and pathogenesis of human polyomavirus infections. Dev Biol Stand 1998; 94: 719.
  • 41
    Bhattacharjee S, Chakraborty T. High reactivation of BK virus variants in Asian Indians with renal disorders and during pregnancy. Virus Genes 2004; 28: 15768.
  • 42
    Pietropaolo V, Di Taranto C, Degener AM, Jin L, Sinibaldi L, Baiocchini A, Melis M, Orsi N. Transplacental transmission of human polyomavirus BK. J Med Virol 1998; 56: 3726.
  • 43
    White MK, Gordon J, Reiss K, Del Valle L, Croul S, Giordano A, Darbinyan A, Khalili K. Human polyomaviruses and brain tumors. Brain Res Brain Res Rev 2005; 50: 6985.
  • 44
    Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004; 14: 45371.
  • 45
    Flaegstad T, Andresen PA, Johnsen JI, Asomani SK, Jorgensen GE, Vignarajan S, Kjuul A, Kogner P, Traavik T. A possible contributory role of BK virus infection in neuroblastoma development. Cancer Res 1999; 59: 11603.
  • 46
    Stolt A, Kjellin M, Sasnauskas K, Luostarinen T, Koskela P, Lehtinen M, Dillner J. Maternal human polyomavirus infection and risk of neuroblastoma in the child. Int J Cancer 2005; 113: 3936.
  • 47
    Reddy UM, Baschat AA, Zlatnik MG, Towbin JA, Harman CR, Weiner CP. Detection of viral deoxyribonucleic acid in amniotic fluid: association with fetal malformation and pregnancy abnormalities. Fetal Diagn Ther 2005; 20: 2037.
  • 48
    Nevels M, Tauber B, Spruss T, Wolf H, Dobner T. “Hit-and-run” transformation by adenovirus oncogenes. J Virol 2001; 75: 308994.
  • 49
    Vilchez RA, Butel JS. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004; 17: 495508.
  • 50
    Shah KV. Does SV40 infection contribute to the development of human cancers? Rev Med Virol 2000; 10: 3143.
  • 51
    Subramani S, Southern PJ. Analysis of gene expression using simian virus 40 vectors. Anal Biochem 1983; 135: 115.
  • 52
    Diamandopoulos GT. Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst 1973; 50: 134765.
  • 53
    Tanaka Y, Tang X, Hou DX, Gao H, Kitabayashi I, Gachelin G, Yokoyama K. Phenotypic conversion of SV40-immortalized human diploid fibroblasts to senescing cells by introduction of an antisense gene for SV40-T antigen. Cell Struct Funct 1992; 17: 35162.
  • 54
    Heinsohn S, Golta S, Kabisch H, zur Stadt U. Standardized detection of simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica 2005; 90: 949.
  • 55
    Rollison DE, Newschaffer CJ, Tao Y, Pollak M, Helzlsouer KJ. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer. Int J Cancer 2006; 118: 127984.
  • 56
    Engels EA, Sarkar C, Daniel RW, Gravitt PE, Verma K, Quezado M, Shah KV. Absence of simian virus 40 in human brain tumors from northern India. Int J Cancer 2002; 101: 34852.
  • 57
    Mayall F, Barratt K, Shanks J. The detection of simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols. J Clin Pathol 2003; 56: 72830.
  • 58
    Gordon GJ, Chen CJ, Jaklitsch MT, Richards WG, Sugarbaker DJ, Bueno R. Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines. Oncol Rep 2002; 9(3): 6314.